Sale!

M. Leprosy RNA Detection Qualitative Test Cost

Original price was: 1,120 د.إ.Current price is: 800 د.إ.

-29%

The M. Leprosy RNA Detection Qualitative Test is a diagnostic assay designed to detect the RNA of the Mycobacterium leprae bacterium, which causes leprosy, also known as Hansen’s disease. This advanced molecular test targets specific genetic material of the bacterium, providing a qualitative result that indicates the presence or absence of M. leprae RNA in the sample. The test is particularly useful for early diagnosis and for confirming suspected cases of leprosy, facilitating timely treatment and management of the disease.

Performed at DNA Labs UAE, a state-of-the-art facility known for its expertise in molecular diagnostics, the test ensures high sensitivity and specificity, minimizing the risk of false positives or negatives. The cost of the M. Leprosy RNA Detection Qualitative Test is set at 800 AED, reflecting the sophisticated technology and expertise involved in conducting the assay. This test represents a significant step forward in the fight against leprosy, offering a reliable tool for healthcare professionals in the diagnosis and control of this ancient disease.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

M. Leprosy RNA Detection Qualitative Test – DNA Labs UAE

Test Name: M. Leprosy RNA Detection Qualitative Test

Components: RNA Detection Kit

Price: 800.0 AED

Sample Condition: Ear Droppings, Lesion curatings, Biopsy of Patches, Scraps of Nasals mucosa, Urine

Report Delivery: 3rd Working Day via Email (36 hours) or Phone (24 hours)

Method: Real Time PCR

Test Type: Viral

Doctor: Physician

Test Department: Genetics

Pre Test Information: Patients need to sign a Consent document and provide any clinical history related to M. Leprosy

Test Details

The M. leprosy RNA detection qualitative test is a diagnostic test used to detect the presence of Mycobacterium leprae, the bacteria that causes leprosy. This test specifically detects the RNA (ribonucleic acid) of the bacteria.

The test is usually performed on a sample taken from a skin lesion or a nerve biopsy. The sample is collected using a sterile swab or a small piece of tissue. The collected sample is then processed in a laboratory to extract the RNA from the bacteria.

The extracted RNA is then subjected to a molecular technique called reverse transcription polymerase chain reaction (RT-PCR). This technique converts the RNA into DNA (deoxyribonucleic acid) and amplifies specific target sequences of the M. leprae DNA. The amplification allows for the detection of even small amounts of the bacteria’s genetic material.

If the M. leprae RNA is detected in the sample, it indicates an active infection with leprosy. This test is highly sensitive and specific for M. leprae, allowing for accurate diagnosis and early detection of the disease.

The M. leprosy RNA detection qualitative test is particularly useful in cases where other diagnostic methods, such as acid-fast bacilli staining or skin smears, have produced inconclusive or negative results. It can also be used to monitor the effectiveness of treatment and to detect relapses in patients with leprosy.

Overall, this test plays a crucial role in the diagnosis and management of leprosy, helping healthcare professionals provide appropriate treatment and prevent the spread of the disease.

Test Name M. Leprosy RNA Detection Qualitative Test
Components
Price 800.0 AED
Sample Condition Ear Droppings, Lesion curatings, Biopsy of Patches, Scraps of Nasals mucosa. urine
Report Delivery 3rd Working Day Email:-36 hours.On phone: 24 hours
Method Real Time PCR
Test type Viral
Doctor Physician
Test Department: Genetics
Pre Test Information Need to sign Consent document and bring any clinical history of patient forM. Leprosy (RNA Detection) QualitativeTest
Test Details

The M. leprosy (RNA detection) qualitative test is a diagnostic test used to detect the presence of Mycobacterium leprae, the bacteria that causes leprosy. This test specifically detects the RNA (ribonucleic acid) of the bacteria.

The test is usually performed on a sample taken from a skin lesion or a nerve biopsy. The sample is collected using a sterile swab or a small piece of tissue. The collected sample is then processed in a laboratory to extract the RNA from the bacteria.

The extracted RNA is then subjected to a molecular technique called reverse transcription polymerase chain reaction (RT-PCR). This technique converts the RNA into DNA (deoxyribonucleic acid) and amplifies specific target sequences of the M. leprae DNA. The amplification allows for the detection of even small amounts of the bacteria’s genetic material.

If the M. leprae RNA is detected in the sample, it indicates an active infection with leprosy. This test is highly sensitive and specific for M. leprae, allowing for accurate diagnosis and early detection of the disease.

The M. leprosy (RNA detection) qualitative test is particularly useful in cases where other diagnostic methods, such as acid-fast bacilli staining or skin smears, have produced inconclusive or negative results. It can also be used to monitor the effectiveness of treatment and to detect relapses in patients with leprosy.

Overall, this test plays a crucial role in the diagnosis and management of leprosy, helping healthcare professionals provide appropriate treatment and prevent the spread of the disease.